Infrequent epigenetic dysregulation of CIP/KIP family of cyclin-dependent kinase inhibitors in multiple myeloma
Open Access
- 10 November 2005
- journal article
- other
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 19 (12), 2352-2355
- https://doi.org/10.1038/sj.leu.2403904
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathwayBlood, 2004
- Promoter hypermethylation of the cyclin-dependent kinase inhibitor (CDKI) gene p21WAF1/CIP1/SDI1 is rare in various lymphomas and carcinomasBlood, 2004
- Disruption of INK4/CDK/Rb cell cycle pathway by gene hypermethylation in multiple myeloma and MGUSLeukemia, 2003
- Proliferation of cancer cells despite CDK2 inhibitionCancer Cell, 2003
- Aberrant DNA methylation ofp57KIP2 gene in the promoter region in lymphoid malignancies of B-cell phenotypeBlood, 2002
- PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrestNature Medicine, 2002
- Hypermethylation of gene promoters in hematological neoplasiaHematological Oncology, 2002
- To cycle or not to cycle: a critical decision in cancerNature Reviews Cancer, 2001
- Contributions in the domain of cancer research: Review¶Negative regulators of cyclin-dependent kinases and their roles in cancersCellular and Molecular Life Sciences, 2001